Volition to host virtual investor event on nu.q® cancer, "a look to the future of cancer diagnostics", on april 9, 2025

Henderson, nev. , march 27, 2025 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, today announces it will host a virtual investor event on wednesday, april 9, 2025, at 10:00 am et, featuring volition's gael forterre, chief commercial officer, dr. andrew retter, chief medical officer and dr. jake micallef, chief scientific officer.
VNRX Ratings Summary
VNRX Quant Ranking